SkinnyRx Reviews: Oral GLP-1 Tablets, Financing & Compounded Pricing Analysis
Review of SkinnyRx: compounded semaglutide from around $199/month and tirzepatide from around $299/month, oral tablet formulations, Affirm financing, and how compounded tablets differ from approved oral GLP-1s.
Affiliate & Medical Disclosure
This article may contain affiliate links and sponsored content. Product recommendations may be influenced by affiliate commissions. This content is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making medical decisions.Read full disclaimer
SkinnyRx is a cash-pay compounded GLP-1 platform that has drawn attention for two things: offering tirzepatide and semaglutide in oral tablet form alongside injections, and accepting Affirm financing to spread the cost. Its published pricing sits in the middle of the compounded market rather than at the bottom. This review evaluates SkinnyRx across pricing, medications, eligibility, fulfilment, support, and competitive positioning.
Quick Takeaway:
- Cash-pay telehealth platform offering compounded semaglutide and tirzepatide
- Independent reviews describe compounded semaglutide from around $199/month and tirzepatide from around $299/month
- Some reviewers report monthly costs typically ranging from about $179 to $300 depending on the medication prescribed
- Offers oral tablet formulations alongside injections
- Accepts Affirm financing, allowing the cost to be spread over instalments
Looking for a Better Alternative?
While SkinnyRx offers oral options and financing, CoreAge Rx is our top-rated favorite for GLP-1 weight loss therapy. CoreAge Rx combines competitive pricing with exceptional customer service, faster medication delivery, and more comprehensive support resources.
Why we recommend CoreAge Rx:
- Lower monthly costs than most competitors ($179–$399 range)
- Faster prescription approval (typically 12–24 hours)
- More extensive provider support included at no extra charge
- Better medication availability during shortages
- Higher patient satisfaction scores (4.7/5)
At around $199 for semaglutide and $299 for tirzepatide, SkinnyRx sits above the cheapest compounded platforms without offering FDA-approved product in exchange. That positioning needs the oral option or the financing to justify it.
New Patient Special: Save up to $200 on your first three months. Same-day prescription approval for qualifying patients. Rated 4.7/5 stars by verified customers. No insurance required.
Overview: What Is SkinnyRx?
SkinnyRx is a direct-to-consumer telehealth platform providing access to compounded GLP-1 weight loss medication through licensed providers and partner pharmacies. It has been covered by several independent GLP-1 provider review sites, which have evaluated it on price transparency, pharmacy traceability, and prescriber involvement.
Two features distinguish it within the compounded segment. First, it offers oral tablet formulations of tirzepatide and semaglutide alongside injections — an option that matters for needle-averse patients, though compounded oral formulations are a different proposition from the FDA-approved oral products. Second, it accepts Affirm, letting patients spread payment over instalments rather than paying monthly in full.
Medications Offered and Compounded Status
SkinnyRx offers compounded semaglutide and compounded tirzepatide, in injectable and oral tablet formulations.
Important: Compounded oral GLP-1 tablets are not the same thing as the FDA-approved oral products. Oral semaglutide is approved and marketed as the Wegovy Pill, and Eli Lilly's oral GLP-1 orforglipron is marketed as Foundayo. A compounded tablet is a pharmacy preparation that has not been reviewed by the FDA for safety, effectiveness, or quality. If an oral option is what you want, understand clearly which of the two you are being offered. See our compounded versus brand-name guide and our alternative treatments guide.
Consultation Process and Provider Involvement
- Online intake. Health history, weight, medications, and goals.
- Provider review. A licensed clinician assesses eligibility and prescribes where appropriate.
- Formulation choice. Injectable or oral tablet, subject to clinical judgement.
- Payment. Pay monthly, or use Affirm financing to spread the cost.
- Delivery and continuation. Medication dispensed by a partner pharmacy and shipped, with ongoing refills.
Independent reviewers have scored platforms in this segment on prescriber involvement and pharmacy traceability — both worth asking about directly, since they vary considerably between compounded providers.
Eligibility and Lab Requirements
Standard anti-obesity medication criteria apply: BMI of 30 or above, or 27 or above with at least one weight-related comorbidity. Contraindications are the class standard — personal or family history of medullary thyroid carcinoma, MEN2 syndrome, pregnancy, breastfeeding, and known hypersensitivity.
Routine baseline laboratory work is generally not required in this segment. Obtain labs independently if you have thyroid, pancreatic, gallbladder, or diabetes history. See our eligibility guide.
Pricing
| Element | Reported pricing |
|---|---|
| Compounded semaglutide | From around $199/month |
| Compounded tirzepatide | From around $299/month |
| Reported typical range | About $179–$300/month depending on medication |
| Oral tablet formulations | Available; confirm pricing directly |
| Financing | Affirm accepted |
| Insurance | Not billed |
| CoreAge Rx | $179–$399 all in |
Pro Tip: Financing makes an expensive treatment feel affordable without making it cheaper. Affirm spreads the cost; it does not reduce it, and interest may apply depending on the plan offered. Before financing GLP-1 therapy, check whether a lower-priced provider, your insurance formulary, or an employer programme removes the need to borrow at all. Our cheapest providers ranking starts with the free options.
Compounded semaglutide and tirzepatide in injectable and oral tablet formulations, with Affirm financing available.
Pharmacy Fulfilment and Shipping
Prescriptions are dispensed by partner compounding pharmacies and shipped to the patient. Independent reviewers have specifically evaluated compounded platforms on pharmacy traceability — whether you can identify the dispensing pharmacy and its regulatory status. Ask which pharmacy fills your prescription and whether it is a 503A pharmacy or an FDA-registered 503B outsourcing facility.
Injectables require cold-chain handling. Oral tablets have different storage requirements; follow the pharmacy label. See our storage and shipping guide.
Support Services
- Licensed provider oversight and prescribing
- Messaging for dose and side-effect questions
- Refill management
- Financing support through Affirm
There is no coaching curriculum, dietitian, or structured behavioural programme.
Cancellation, Refunds, Insurance, and HSA/FSA
Confirm cancellation and refund terms in writing before subscribing. As across this segment, dispensed compounded medication cannot be returned to stock, so refunds on shipped product are generally unavailable. Financing arrangements add a second consideration: an Affirm plan is a credit agreement that continues independently of whether you stop treatment. Understand both sets of terms before committing.
SkinnyRx does not bill insurance. Medically supervised weight management is generally an eligible HSA and FSA expense; keep itemised receipts and confirm with your administrator.
Pros and Cons
Pros
- Oral tablet formulations available alongside injections
- Affirm financing spreads the cost
- Both semaglutide and tirzepatide offered
- Covered and scored by several independent provider trackers
- Straightforward cash-pay model with no insurance complexity
Cons
- Pricing above the cheapest compounded platforms without FDA-approved product in exchange
- Compounded oral tablets are not the FDA-approved oral GLP-1 products
- Financing adds a credit obligation separate from treatment
- No coaching, nutrition, or behavioural support
- No insurance billing and no routine lab requirement
Who It May Be Best For, and Limitations
Best for: Patients who specifically want an oral formulation from a compounded provider, and patients for whom spreading payment through financing makes treatment accessible.
Limitations: Cost-focused patients will find cheaper compounded options; patients wanting approved oral GLP-1s should look at the Wegovy Pill or Foundayo; and anyone with insurance coverage should pursue that first.
Alternatives to SkinnyRx
| Provider | Model | What differs |
|---|---|---|
| CoreAge Rx | Bundled GLP-1 | All-in $179–$399 with included support |
| Gimme Care | Flat-price compounded | Tirzepatide $163/month at any dose |
| Refills | Flat-price compounded | Semaglutide advertised at $99/month |
| Sesame | Care + branded drug | Wegovy Pill from $149/month, FDA-approved |
| Second Nature | UK programme | Foundayo oral GLP-1 programme at £129–£179 |
Frequently Asked Questions
How much does SkinnyRx cost?
Independent reviews describe compounded semaglutide from around $199 per month and compounded tirzepatide from around $299 per month, with some reporting a typical range of about $179 to $300 depending on the medication prescribed. Verify current pricing directly.
Does SkinnyRx offer GLP-1 pills?
SkinnyRx offers compounded oral tablet formulations of tirzepatide and semaglutide alongside injections. These are compounded preparations and are not the same as the FDA-approved oral products — oral semaglutide is marketed as the Wegovy Pill, and orforglipron as Foundayo.
Can I finance SkinnyRx treatment?
Yes. SkinnyRx accepts Affirm, which spreads payment over instalments. Financing does not reduce the total cost, and interest may apply depending on the plan.
Does SkinnyRx take insurance?
No. It operates on a cash-pay basis. Costs may be reimbursable through an HSA or FSA.
Are compounded oral GLP-1 tablets as effective as injections?
The pivotal efficacy evidence for GLP-1 therapy comes from FDA-approved products at defined doses, not from compounded oral formulations. There is no equivalent trial evidence for compounded tablets, so effectiveness should not be assumed to match either approved oral products or injections.
Which pharmacy dispenses SkinnyRx medication?
Ask directly. Independent reviewers score compounded platforms partly on pharmacy traceability, and the distinction between a 503A pharmacy and an FDA-registered 503B outsourcing facility is a meaningful difference in oversight.
Bottom Line
SkinnyRx's oral formulations and financing option address two real barriers — needle aversion and upfront cost — but neither comes free. Compounded oral tablets sit outside the evidence base that supports approved oral GLP-1s, and financing spreads cost rather than reducing it.
Strengths: oral options, financing available, both medications offered, independently covered.
Drawbacks: mid-range pricing without FDA-approved product, compounded tablets lacking trial evidence, credit obligations, and no behavioural support.
Best for: patients who need an oral option from a compounded provider or who require financing to start.
Skip if: you want the lowest cost, approved oral medication, or insurance pursued.
If an oral GLP-1 is what you actually want, compare the approved products first — the Wegovy Pill has been offered from $149 per month through Sesame, which is both cheaper and FDA-approved.
CoreAge Rx: one all-in monthly price from $179–$399 including medication, provider messaging, and titration support, with no financing required. Save up to $200 on your first three months.
Medical disclaimer: Informational only, not medical or financial advice. GLP-1 receptor agonists are prescription medicines with real risks and contraindications. Compounded medications, including oral formulations, are not FDA-approved products. Consult a qualified healthcare professional before starting or changing treatment.
Sources: Independent GLP-1 provider review and price-tracking sites covering SkinnyRx; FDA guidance on human drug compounding; FDA prescribing information.
Date reviewed: August 2026
About the Author
Dr. Robert Janssen
Clinical Pharmacologist, Amsterdam Medical Center